Unexplained weight loss (UWL) is a common yet perplexing clinical presentation, often posing significant diagnostic challenges for clinicians. While it may be an indicator of underlying malignancy, infection, or other systemic diseases, in many instances, no clear etiology is found despite comprehensive evaluation.
The first step involves a comprehensive history and physical examination. Attention should be given to dietary intake, gastrointestinal symptoms, and psychosocial factors. Additionally, a review of medications can reveal possible iatrogenic causes. The physical examination should focus on signs of malnutrition, cachexia, and evidence of systemic disease.
Initial laboratory studies should include a complete blood count, comprehensive metabolic panel, thyroid function tests, and inflammatory markers. If these are inconclusive, further testing such as imaging studies or endoscopies may be warranted. However, the yield of these tests is often low without specific indications.
In elderly patients, UWL may be a sign of frailty or sarcopenia. In such cases, a comprehensive geriatric assessment can be beneficial. For patients with psychiatric symptoms, a thorough mental health evaluation is necessary as depression and anxiety are common causes of UWL.
Management is primarily directed at the underlying cause, if identified. In cases where no cause is found, emphasis should be placed on nutritional support and regular follow-up to monitor for the development of new symptoms or signs. It's crucial to maintain a high index of suspicion for serious underlying disease, especially in patients with significant weight loss.
Evaluating UWL requires a methodical and patient-centered approach. While it can be a diagnostic quandary, a comprehensive approach can help identify the cause in most patients, guiding appropriate treatment and follow-up. Continued research is needed to improve our understanding and management of this complex clinical scenario.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation